RADX Stock Overview

Profile

Full Name:

Radiopharm Theranostics Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

December 5, 2024

Indexes:

Not included

Website:

http://www.radiopharmtheranostics.com

Description:

A biotechnology company focused on developing and commercializing radiopharmaceuticals for the diagnosis and treatment of cancer and other diseases.

Key Details

Price

$6.60

Market Cap

$51.35 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$196.20 K(-0.25% YoY)

Annual EPS

-$24.41(-13.10% YoY)

PE Ratio

-

Annual ROE

-129.75%

Annual Debt To Equity

0.00

Beta

-1.42

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with RADX included

Growing Shares Outstanding
Biggest stock gainers today
Stocks above SMA 50
Healthcare sector
All stocks
Stocks above SMA 200
Biotechnology industry
Small cap stocks
Stocks with low beta
Stocks with high RSI

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$6.60
RADX price is $6.60

Price All-time High

$18.90
RADX price is currently -65.08% below its historical high of $18.90

Price Analysts Target

-
RADX price consensus analysts' forecast is unknown

Price Most Recent Change

+12.82%
RADX price was up +12.82% on Mar 6, 2025

Price YTD Change

+46.99%
RADX price is up +46.99% since January 1st

Price 3-Year Change

-
RADX price 3-year change is unknown

Market cap

Market Cap

$51.35 M
RADX market capitalization is $51.35 million

Market Cap 3-Year Change

-
RADX market capitalization 3-year change is unknown

Market Cap All-time High

$136.90 M
RADX market capitalization is currently -62.49% below its historical high of $136.90 million

Market Cap Sector Rank

36.13%
RADX market capitalization is higher than 36.13% of companies in Healthcare sector

Technical

Beta

-1.42
RADX beta is -1.42

200-day SMA

$5.44
RADX price is currently +21.34% above its 200-day simple moving average

14-day RSI

78.86
RADX 14-day relative strength index is 78.86

30-day Relative Volume

2.26
RADX 30-day relative volume is 2.26

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$196.20 K
RADX annual revenue is $196.20 thousand

Annual Revenue Analysts Estimate

$21.27 M
RADX annual revenue is currently -99.08% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-0.25%
RADX annual revenue is down -0.25% year-on-year

Annual Revenue Sector Rank

9.44%
RADX annual revenue is higher than 9.44% of companies in Healthcare sector

Profit

Annual Gross Profit

$196.20 K
RADX annual gross profit is $196.20 thousand

Annual Gross Margin

-
RADX annual gross profit margin value is unknown

Annual Operating Profit

-$24.01 M
RADX annual operating income is -$24.01 million

Annual Operating Margin

-12.24 K%
RADX annual operating profit margin is -12.24 thousand%

Annual Net Income

-$31.43 M
RADX annual net profit is -$31.43 million

Annual Net Margin

-16.02 K%
RADX annual net profit margin is -16.02 thousand%

EPS

Annual EPS

-$24.41
RADX annual earnings per share is -$24.41

Annual EPS Analysts Estimate

-
RADX annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-13.1%
RADX annual earnings per share is down -13.1% year-on-year

Annual EPS Sector Rank

9.67%
RADX annual earnings per share is higher than 9.67% of companies in Healthcare sector

ROA & ROE

Annual ROA

-64.31%
RADX annual return on assets is -64.31%

Annual ROE

-129.75%
RADX annual return on equity is -129.75%

EBIT & EBITDA

Annual EBIT

-$30.95 M
RADX annual earnings before interest & taxes is -$30.95 million

Annual EBITDA

-$28.90 M
RADX annual EBITDA is -$28.90 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
RADX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
RADX price to earnings ratio is unknown

PB Ratio

PB Ratio

2.73
RADX price to book ratio is 2.73

PB Ratio Sector Rank

67.82%
RADX price to book ratio is higher than 67.82% of companies in Healthcare sector

PS Ratio

PS Ratio

-
RADX price to sales ratio value is unknown

PS Ratio Sector Rank

-
RADX price to sales ratio is unknown

Enterprise value

Enterprise Value

$38.93 M
RADX enterprise value is $38.93 million

Enterprise Value Sector Rank

37.41%
RADX enterprise value is higher than 37.41% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
RADX EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
RADX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.30
RADX annual current ratio is 1.30

Annual Quick Ratio

-
RADX annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
RADX annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-73.43
RADX annual interest coverage ratio is -73.43

Risk & Stability

Piotroski F-Score

-
RADX piotroski f-score value is unknown

Altman Z-Score

-3.16
RADX altman z-score is -3.16

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$48.15 M
RADX annual total assets is $48.15 million

Annual Non Current Assets

$32.88 M
RADX annual long term assets is $32.88 million

Annual Current Assets

$15.27 M
RADX annual total current assets is $15.27 million

Annual Cash & Cash Equivalents

$12.42 M
RADX annual cash & cash equivalents is $12.42 million

Equity

Annual Book Value

$18.80 M
RADX annual book value is $18.80 million

Annual Working Capital

$3.52 M
RADX annual working capital is $3.52 million

Liabilities

Annual Total Liabilities

$29.87 M
RADX annual total liabilities is $29.87 million

Annual Total Long Term Liabilities

$18.12 M
RADX annual total long term liabilities is $18.12 million

Annual Current Liabilities

$11.75 M
RADX annual total current liabilities is $11.75 million

Annual Accounts Payable

$4.30 M
RADX annual accounts payable is $4.30 million

Debt

Annual Total Debt

$0.00
RADX annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
RADX {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
RADX annual long term debt value is unknown

Annual Short Term Debt

-
RADX annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

-
RADX annual total expenses value is unknown

Annual Operating Expenses

$24.20 M
RADX annual total operating expenses is $24.20 million

Annual Cost Of Goods Sold

-
RADX annual cost of goods sold value is unknown

Annual SGA

$9.98 M
RADX annual SGA is $9.98 million

Annual D&A

-
RADX annual depreciation & amortization value is unknown

Annual Interest Expense

$421.50 K
RADX annual interest expense is $421.50 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-
RADX annual cash flow from operations value is unknown

Annual CFO 1-Year Change

-
RADX annual cash flow from operations 1-year change is unknown

Annual CFI

-
RADX annual cash flow from investing activities value is unknown

Annual CFI 1-Year Change

-
RADX annual cash flow from investing activities 1-year change is unknown

Annual CFF

$19.59 M
RADX annual cash flow from financing activities is $19.59 million

Annual CFF 1-Year Change

+215.82%
RADX annual cash flow from financing activities is up +215.82% year-on-year

Free CashFlow

Annual FCF

-
RADX annual free cash flow value is unknown

Annual FCF 1-Year Change

-
RADX annual free cash flow 1-year change is unknown

CAPEX

Annual CAPEX

-
RADX annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
RADX annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

ALVR logo
AlloVir (ALVR)
KPTI logo
Karyopharm Therapeutics (KPTI)
TOI logo
Oncology Institute (TOI)
RANI logo
Rani Therapeutics Holdings (RANI)
OMIC logo
Singular Genomics Systems (OMIC)
CTMX logo
CytomX Therapeutics (CTMX)
SER logo
Serina Therapeutics (SER)
RPTX logo
Repare Therapeutics (RPTX)
CCLD logo
CareCloud (CCLD)

FAQ

  • What is the ticker symbol for Radiopharm Theranostics Limited?
  • Does Radiopharm Theranostics Limited pay dividends?
  • What sector is Radiopharm Theranostics Limited in?
  • What industry is Radiopharm Theranostics Limited in?
  • What country is Radiopharm Theranostics Limited based in?
  • When did Radiopharm Theranostics Limited go public?
  • Is Radiopharm Theranostics Limited in the S&P 500?
  • Is Radiopharm Theranostics Limited in the NASDAQ 100?
  • Is Radiopharm Theranostics Limited in the Dow Jones?
  • When does Radiopharm Theranostics Limited report earnings?

What is the ticker symbol for Radiopharm Theranostics Limited?

The ticker symbol for Radiopharm Theranostics Limited is NASDAQ:RADX

Does Radiopharm Theranostics Limited pay dividends?

No, Radiopharm Theranostics Limited does not pay dividends

What sector is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Healthcare sector

What industry is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Biotechnology industry

What country is Radiopharm Theranostics Limited based in?

Radiopharm Theranostics Limited is headquartered in Australia

When did Radiopharm Theranostics Limited go public?

Radiopharm Theranostics Limited's initial public offering (IPO) was on December 5, 2024

Is Radiopharm Theranostics Limited in the S&P 500?

No, Radiopharm Theranostics Limited is not included in the S&P 500 index

Is Radiopharm Theranostics Limited in the NASDAQ 100?

No, Radiopharm Theranostics Limited is not included in the NASDAQ 100 index

Is Radiopharm Theranostics Limited in the Dow Jones?

No, Radiopharm Theranostics Limited is not included in the Dow Jones index

When does Radiopharm Theranostics Limited report earnings?

The date for Radiopharm Theranostics Limited's next earnings report has not been announced yet